Skip to main content

Advertisement

Log in

Reduction in the impact of chronic migraine with medication overuse after day-hospital withdrawal therapy

  • Oral Communication
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

The 6-item Headache Impact Test questionnaire (HIT-6) is a simple and reliable tool to measure the impact headaches have on patients’ lives. Patients with chronic migraine (CM) and medication overuse are markedly impaired in their functional activity. The aim of this study was to investigate the responsiveness of the HIT-6 tool to clinical changes induced by treatment in patients with CM and medication overuse. A sample of 160 patients underwent a day-hospital withdrawal treatment followed by prophylaxis. Sixty-two of them completed the 12-month follow up. Patients improved significantly after treatment intervention, as days of headache per month and medications/month decreased from baseline to follow up. Also HIT-6 scores improved, with mean score decreasing from 65±5.4 (median 65) to 59.4±8.5 (median 62) (Student’s t-test p<0.00001) and with a reduction in the percentage of patients with very severe headache-related impact one year after withdrawal therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lipton RB, Hamelsky S, Kolodner KB et al (2000) Migraine, quality of life and depression: a population based case-control study. Neurology 55:629–635

    PubMed  CAS  Google Scholar 

  2. Terwindt G, Ferrari M, Tihuis M et al (2000) The impact of migraine on quality of life in the general population: the GEM study. Neurology 55:624–629

    PubMed  CAS  Google Scholar 

  3. Matchar DB, Young WB, Rosenerg J et al and the US Headache Consortium (2000) Multispecialty consensus on diagnosis and treatment of headache: pharmacological management of acute attacks. www.aan.com/professionals/practice/pdfs/gl0087.pdf

  4. Ramadan NM, Silberstein SD, Freitag FG et al and the US Headache Consortium. Evidence-based guidelines for migraine headache in the primary care setting: pharmacological management for prevention of migraine. www.aan.com/professionals/practice/pdfs/gl0090.pdf

  5. Kosinski M, Bayliss MS, Bjorner JB et al (2003) A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res 12:963–974

    Article  PubMed  CAS  Google Scholar 

  6. Kawata AK, Coeytaux RR, Devellis RF et al (2005) Psychometric properties of the HIT-6 among patients in a headache-specialty practice. Headache 45:638–643

    Article  PubMed  Google Scholar 

  7. De Diego EV, Lanteri-Minet M (2005) Recognition and management of migraine in primary care: influence of functional impact measured by the headache impact test (HIT). Cephalalgia 25:184–190

    Article  PubMed  Google Scholar 

  8. Coeytaux RR, Linville JC (2007) Chronic daily headache in a primary care population: prevalence and headache impact test scores. Headache 47:7–12

    Article  PubMed  Google Scholar 

  9. Monzon MJ, Lainez MJ (1998) Quality of life in migraine and chronic daily headache patients. Cephalalgia 18:638–643

    Article  PubMed  CAS  Google Scholar 

  10. Meletiche DM, Lofland JH, Young WB (2001) Quality-of life differences between patients with episodic and transformed migraine. Headache 41:573–578

    Article  PubMed  CAS  Google Scholar 

  11. Wang SJ, Fuh JL, Lu SR, Juang KD (2001) Quality of life differs among headache diagnoses: analysis of SF-36 survey in 901 headache patients. Pain 89:285–292

    Article  PubMed  CAS  Google Scholar 

  12. Guitera V, Munoz P, Castillo J, Pascual J (2002) Quality of life in chronic daily headache: a study in a general population. Neurology 58:1062–1065

    PubMed  Google Scholar 

  13. Magnusson JE, Becker WJ (2002) A comparison of disability and psychological factors in migraine and transformed migraine. Cephalalgia 22:172–178

    Article  PubMed  CAS  Google Scholar 

  14. Bigal ME, Rapoport AM, Lipton RB et al (2003) Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine. Headache 43:336–342

    Article  PubMed  Google Scholar 

  15. D’Amico D, Grazzi L, Usai S et al (2005) Disability pattern in chronic migraine with medication overuse: a comparison with migraine without aura. Headache 45:553–560

    Article  PubMed  Google Scholar 

  16. Silberstein SD, Lipton RB (2000) Chronic daily headache. Curr Opin Neurol 13:277–283

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Susanna Usai.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Usai, S., Grazzi, L., D’Amico, D. et al. Reduction in the impact of chronic migraine with medication overuse after day-hospital withdrawal therapy. Neurol Sci 29 (Suppl 1), 176–178 (2008). https://doi.org/10.1007/s10072-008-0918-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-008-0918-1

Keywords

Navigation